Retraction to: Cell Death and Disease (2021) 12:733 https://doi.org/10.1038/s41419-021-04023-w, published online 23 July 2021
The Editors-in-Chief have retracted this article after concerns were reported about some of the data presented. After publication, it was identified that the Western blot image for the β-actin control in Fig. 6B had been re-used in Fig. 5J. Areas of apparent overlap were also identified in some the flow cytometry plots presented in the supplementary materials. The Editors-in-Chief therefore no longer have confidence in the reliability of their conclusions. The authors did not respond to correspondence from the publisher about this retraction.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liu, G., Yu, J., Wu, R. et al. Retraction Note: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death. Cell Death Dis 15, 188 (2024). https://doi.org/10.1038/s41419-024-06574-0
Published:
DOI: https://doi.org/10.1038/s41419-024-06574-0
